Regulation of Nucleoporins by Interferon

干扰素对核孔蛋白的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): The movement of molecules between the nucleus and the cytoplasm of eukaryotic cells is mediated by, the nuclear transport machinery. In general, to be imported or exported from the nucleus, molecules 1) bind to transport receptors, 2) are transported through nuclear pore complexes (NPCs) present in the nuclear envelope, 3) and translocate from the NPCs to intranuclear or cytoplasmic target sites. These are crucial steps for controlling nuclear entry and exit of molecules such as transcription factors, RNAs, kinases and viral particles. Disruption of this machinery has been involved in cancer. NPC proteins (nucleoporins or Nups) are associated with chromosomal rearrangements in leukemia. Nups are also targets of viral proteins. Our recent findings show that up-regulation of two major Nups, Nup98 and Nup96, by interferon (IFN) reverts mRNA nuclear export inhibition mediated by a viral protein. These results indicate a role for Nups in antiviral response and in other IFN-mediates processes such as innate immunity and cell proliferation. Our long-range goal is to understand the molecular mechanisms of the nuclear transport machinery and how they are, regulated by different signaling pathways. The central hypothesis is that a subset of Nups are highly regulated by extracellular signals, facilitate nuclear import and export of molecules, and are also target of viral proteins and other pathogenic factors. We will pursue the following specific aims: 1. To characterize Sec 13 and novel constituents of the Nup98 and Nup96-mediated nuclear transport pathway(s). 2. To determine the role of Secl3 and novel constituents of the Nup98 and Nup96-mediated pathway(s) on the structure, active and passive transport at the NPC. 3. Determine the molecular mechanisms involved in the disruption of Nup98 and Nup96 function by a viral protein and their regulation by the IFN pathway. High-resolution microscopies, biochemical and genetic approaches will be used. Thus, our research proposes innovative findings on Nup function and regulation, which are crucial to advance the nuclear transport field and are also essential for understanding the role of Nups in leukemia and IFN-mediated processes, such as antiviral response, innate immunity and cell proliferation.
描述(由申请人提供):真核细胞的细胞核和细胞质之间的分子运动是由核转运机制介导的。一般来说,要从细胞核输入或输出,分子1)与转运受体结合,2)通过存在于核膜中的核孔复合物(NPCs)运输,3)从NPCs转运到核内或细胞质目标位点。这是控制转录因子、rna、激酶和病毒颗粒等分子进入和退出核的关键步骤。这种机制的破坏与癌症有关。NPC蛋白(核孔蛋白或Nups)与白血病的染色体重排有关。糖蛋白也是病毒蛋白的目标。我们最近的研究结果表明,干扰素(IFN)上调Nup98和Nup96这两个主要的Nup98和Nup96,可以逆转由病毒蛋白介导的mRNA核输出抑制。这些结果表明,Nups在抗病毒反应和其他ifn介导的过程(如先天免疫和细胞增殖)中发挥作用。我们的长期目标是了解核转运机制的分子机制,以及它们是如何被不同的信号通路调节的。核心假设是Nups的一个子集受到细胞外信号的高度调节,促进分子的核进出口,也是病毒蛋白和其他致病因子的靶点。具体目标是:表征Sec 13和Nup98和nup96介导的核转运途径的新成分。2. 目的:确定Nup98和nup96介导通路的新组分和隐居3在鼻咽癌的结构、主动和被动转运中的作用。3. 确定病毒蛋白破坏Nup98和Nup96功能的分子机制及其通过IFN途径的调控。将使用高分辨率显微镜、生化和遗传方法。因此,我们的研究提出了关于Nup功能和调控的创新发现,这对推进核转运领域至关重要,也对理解Nup在白血病和ifn介导的过程中的作用至关重要,如抗病毒反应、先天免疫和细胞增殖。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Beatriz MA Fontoura其他文献

Beatriz MA Fontoura的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Beatriz MA Fontoura', 18)}}的其他基金

Virulence Factor at the Interface of Viral and Cellular mRNA Nuclear Export
病毒和细胞 mRNA 核输出界面的毒力因子
  • 批准号:
    10394386
  • 财政年份:
    2020
  • 资助金额:
    $ 26.97万
  • 项目类别:
Virulence Factor at the Interface of Viral and Cellular mRNA Nuclear Export
病毒和细胞 mRNA 核输出界面的毒力因子
  • 批准号:
    10066684
  • 财政年份:
    2020
  • 资助金额:
    $ 26.97万
  • 项目类别:
Virulence Factor at the Interface of Viral and Cellular mRNA Nuclear Export
病毒和细胞 mRNA 核输出界面的毒力因子
  • 批准号:
    10604277
  • 财政年份:
    2020
  • 资助金额:
    $ 26.97万
  • 项目类别:
Virulence Factor at the Interface of Viral and Cellular mRNA Nuclear Export
病毒和细胞 mRNA 核输出界面的毒力因子
  • 批准号:
    10159852
  • 财政年份:
    2020
  • 资助金额:
    $ 26.97万
  • 项目类别:
Chemical intervention of influenza virus RNA nuclear export
化学干预流感病毒RNA核输出
  • 批准号:
    9488801
  • 财政年份:
    2015
  • 资助金额:
    $ 26.97万
  • 项目类别:
Chemical intervention of influenza virus RNA nuclear export
化学干预流感病毒RNA核输出
  • 批准号:
    8956127
  • 财政年份:
    2015
  • 资助金额:
    $ 26.97万
  • 项目类别:
Using Chemical Biology to Interfere with the Influenza Virus Life Cycle
利用化学生物学干扰流感病毒的生命周期
  • 批准号:
    8662161
  • 财政年份:
    2010
  • 资助金额:
    $ 26.97万
  • 项目类别:
Novel Inhibitors of Viral Replication
病毒复制的新型抑制剂
  • 批准号:
    8302415
  • 财政年份:
    2010
  • 资助金额:
    $ 26.97万
  • 项目类别:
Novel Inhibitors of Viral Replication
病毒复制的新型抑制剂
  • 批准号:
    7939350
  • 财政年份:
    2010
  • 资助金额:
    $ 26.97万
  • 项目类别:
Using Chemical Biology to Interfere with the Influenza Virus Life Cycle
利用化学生物学干扰流感病毒的生命周期
  • 批准号:
    7784147
  • 财政年份:
    2010
  • 资助金额:
    $ 26.97万
  • 项目类别:

相似海外基金

Creation of a microplasma device for active transport of macromolecular drugs to in vivo tissue
创建用于将大分子药物主动转运至体内组织的微等离子体装置
  • 批准号:
    23K17473
  • 财政年份:
    2023
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Study on active transport phenomena for predicting and controlling biological active matter
预测和控制生物活性物质的主动输运现象研究
  • 批准号:
    21H04999
  • 财政年份:
    2021
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Analyzing linked safety data to improve active transport safety in BC
分析关联的安全数据以改善 BC 省的主动交通安全
  • 批准号:
    449180
  • 财政年份:
    2021
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Fellowship Programs
Advancing cycling as an active transport mode using data driven approaches
使用数据驱动的方法将自行车作为一种主动交通方式推进
  • 批准号:
    FT210100183
  • 财政年份:
    2021
  • 资助金额:
    $ 26.97万
  • 项目类别:
    ARC Future Fellowships
STTR Phase I: Active Transport of Caffeine through a Blood-Brain Barrier Model
STTR 第一阶段:通过血脑屏障模型主动转运咖啡因
  • 批准号:
    2014346
  • 财政年份:
    2020
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Standard Grant
Structural biology of active transport and its regulation by P-type ATPases
主动转运的结构生物学及其 P 型 ATP 酶的调控
  • 批准号:
    19H00975
  • 财政年份:
    2019
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Collaborative Research: Active Transport of Lipid Vesicles in Osmotic Gradients
合作研究:渗透梯度下脂质囊泡的主动运输
  • 批准号:
    1952295
  • 财政年份:
    2019
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Standard Grant
Effects of stoppage evasion of active transport and pressurized dissolution of a hydrophobic gas on cellular damage in cold storage.
主动运输的停止规避和疏水性气体的加压溶解对冷藏中细胞损伤的影响。
  • 批准号:
    19K04222
  • 财政年份:
    2019
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Collaborative Research: Active Transport of Lipid Vesicles in Osmotic Gradients
合作研究:渗透梯度下脂质囊泡的主动运输
  • 批准号:
    1804836
  • 财政年份:
    2018
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Standard Grant
Collaborative Research: Active Transport of Lipid Vesicles in Osmotic Gradients
合作研究:渗透梯度下脂质囊泡的主动运输
  • 批准号:
    1804332
  • 财政年份:
    2018
  • 资助金额:
    $ 26.97万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了